China Cell and Gene Therapy Manufacturing QC Market Overview 2025-2028

Table Of Content

1. Executive Summary
   1. China Cell and Gene Therapy Manufacturing QC Market Definition
   2. China Cell and Gene Therapy Manufacturing QC Market Snapshot
   3. Key Investment Opportunities
   4. Key Success Tactics
   5. Key Influencing Elements
2. Research Scope & Segmentation
   1. Research Objectives
   2. Limitations & Assumptions
   3. China Cell and Gene Therapy Manufacturing QC Market Scope & Segmentation
   4. Currency & Pricing Considered
3. China Cell and Gene Therapy Manufacturing QC Market Opportunity Assessment
   1. Emerging Regions / Countries
   2. Emerging Companies
   3. Emerging Applications / End Use
4. China Cell and Gene Therapy Manufacturing QC Market Dynamics
   1. China Cell and Gene Therapy Manufacturing QC Market Drivers
   2. China Cell and Gene Therapy Manufacturing QC Market Warning Factors
   3. Latest Macro Economic Indicators
   4. Geopolitical Impact
   5. Technology Factors
5. China Cell and Gene Therapy Manufacturing QC Market Assessment
   1. Porter's Five Forces Analysis
   2. Value Chain Analysis
   3. PESTLE Analysis
6. China Cell and Gene Therapy Manufacturing QC Market Segmentation
   
   1. China Cell and Gene Therapy Manufacturing QC Market By Therapy Type (2021-2028)
      1. Cell Therapy
      2. Gene Therapy
   2. China Cell and Gene Therapy Manufacturing QC Market By Cell Therapy (2021-2028)
      1. CAR-T
      2. CAR-NK
      3. B-Cell
      4. Other
   3. China Cell and Gene Therapy Manufacturing QC Market By CAR-T (2021-2028)
      1. Autologous CAR-T
      2. Allogeneic CAR-T
   4. China Cell and Gene Therapy Manufacturing QC Market By Gene Therapy (2021-2028)
      1. Viral
      2. Non-Viral
   5. China Cell and Gene Therapy Manufacturing QC Market By Viral (2021-2028)
      1. AAV
      2. Lentiviral vectors
      3. Other
   6. China Cell and Gene Therapy Manufacturing QC Market By Scale (2021-2028)
      1. Pre commercial/ R&D Manufacturing
      2. Commercial Scale Manufacturing
   7. China Cell and Gene Therapy Manufacturing QC Market By Mode (2021-2028)
      1. Contract Manufacturing
      2. In-house Manufacturing
   8. China Cell and Gene Therapy Manufacturing QC Market By Workflow (2021-2028)
      1. Cell Processing
      2. Cell Banking
      3. Fill & Finish Operations
      4. Raw Material Testing
      5. Vector Production
      6. Other Workflows
   9. China Cell and Gene Therapy Manufacturing QC Market By Process (2021-2028)
      1. Upstream Processes
      2. Downstream Processes
   10. China Cell and Gene Therapy Manufacturing QC Market By End User (2021-2028)
       1. Pharmaceutical Companies
       2. Biopharmaceutical / Biotechnological Companies
       3. Contract Manufacturing Organizations
   11. China Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   12. China Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   13. China Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations (2021-2028)
       1. Small Size
       2. Medium Size
       3. Large Size
   14. China Cell and Gene Therapy Manufacturing QC Market By Technology Type (2021-2028)
       1. Fluorescence-Activated Cell Sorting (FACS)
       2. Enzyme-Linked Immunosorbent Assay (ELISA)
       3. Chromatography
       4. Next-Generation Sequencing (NGS)
       5. Polymerase Chain Reaction (PCR)
       6. Others 
7. Competitive Landscape
   1. China Cell and Gene Therapy Manufacturing QC Market Share By Players
   2. M&A Agreements & Collaboration Analysis
8. Company Profiles
9. Research Methodology